Biological response modifiers: the new immunotherapy

Cancer Res. 1989 Apr 1;49(7):1621-39.

Author

K A Foon¹

Affiliation

¹ Division of Clinical Immunology, Roswell Park Memorial Institute, Buffalo, New York 14263.

PMID: 2466558

No abstract available

Publication types

Review

MeSH terms

Antibodies, Monoclonal / therapeutic use
Colony-Stimulating Factors / therapeutic use
Humans
Immunotherapy*
Immunotoxins / therapeutic use
Interferons / therapeutic use
Interleukin-2 / therapeutic use
Killer Cells, Natural / immunology
Neoplasms / therapy*
Tumor Necrosis Factor-alpha / therapeutic use

Substances

Antibodies, Monoclonal
Colony-Stimulating Factors
Immunotoxins
Interleukin-2
Tumor Necrosis Factor-alpha
Interferons